KCTV: Saint Luke's Study Finds GLP-1 Medications May Improve Addictive Behaviors

Researchers at Saint Luke’s Mid America Heart Institute are sharing the latest results of an observational study that revealed weight loss medications may be effective in addressing addictive behaviors like recreational drug use, alcohol consumption, and food cravings.

Dr. James O’Keefe, a co-investigator of this study and director of preventive cardiology at the Mid America Heart Institute, talked with KCTV about the possible new benefits of GLP-1 receptor agonists like Ozempic®.